# Emerge Technologies Inc – FDA 483, Apr 24, 2026

Source: https://www.keypedia.com/records/483/emerge-technologies-inc/4a50bab7-f3e9-4fe9-bd55-0e9ba90375e5

> FDA 483 for Emerge Technologies Inc on April 24, 2026. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Emerge Technologies Inc
- Inspection Date: 2026-04-24
- Product Type: device
- Office Name: Dallas District Office
- Summary: Emerge Technologies Inc, an initial importer and repackager/relabeler in Coppell, TX, was cited with 12 observations during an FDA inspection. The inspection revealed widespread deficiencies in the firm's quality management system, including a lack of documented procedures for critical processes like risk management, purchasing, complaint handling, CAPA, MDR, management review, internal audits, and training. Additionally, the firm failed to validate its ERP software and did not comply with Unique Device Identifier (UDI) labeling requirements for its medical devices.

## Related Officers

- [Elizabeth A. Krolczyk](https://www.keypedia.com/people/elizabeth-a-krolczyk/ecf57c43-b88d-4f84-962b-9067eaad4a7c)

Company: https://www.keypedia.com/companies/emerge-technologies-inc/8d3b7821-cb87-4113-b326-8fc469c25ede

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9